Metformin and risk factors for chronic kidney disease in a European population based on Mendelian randomization
{{output}}
Background: Metformin, widely used for type 2 diabetes, raises concerns about its use in chronic kidney disease (CKD) due to risks like lactic acidosis and renal function impact. This study uses Mendelian randomization (MR) and s... ...
